It is a pharma private limited company based in Delhi, Delhi, India, established in 2000.
2000 | Delhi, Delhi, India | ActiveMetro Pharmaceuticals Private Limited, a active private limited company, was established on 04 February 2000 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239DL2000PTC103605. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Rohit Mahajan (Whole-Time Director), Seema Mahajan (Director). Past directors included Gagan Gupta, Neelam Gupta, Rohit Mahajan. It holds ₹1.28 Cr open charges and ₹4.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at I-45 Lajpat Nagar-1, Delhi, Delhi, 110024.
U24239DL2000PTC103605
103605
04 February 2000
₹5.00 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Metro Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohit Mahajan | Whole-Time Director | 04 Feb 2000 | Current |
| Seema Mahajan | Director | 19 Dec 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Nov 2022 | Past |
| Pramod Abcsdd | Director | 06 May 2025 | Past |
| Pramod Abcsdd | Director | 15 Sep 2016 | Past |
| Pramod Abcsdd | Director | 30 Oct 2009 | Past |
| Pramod Abcsdd | Director | 30 Oct 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Metro Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 12.39% decrease. The company also saw a substantial fall in profitability, with a 25.08% decrease in profit. The company's net worth moved up by a moderate rise of 4.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Metro Pharmaceuticals had a promoter holding of 20.68% and a public holding of 79.32%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,796,200.00
₹4,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2013 | Hdfc Bank Limited | ₹1.28 Cr | Open |
| 08 Mar 2022 | Others | ₹1.40 M | Satisfied |
| 26 Mar 2011 | Canara Bank | ₹0.80 M | Satisfied |
| 28 Jan 2005 | State Bank Of India | ₹1.50 M | Satisfied |
| 09 Mar 2002 | Bank Of Baroda | ₹0.30 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Metro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Metro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Metro Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 08 Mar 2022 via Charge ID 100555886 with Others was fully satisfied on 22 Apr 2025. was documented.
Metro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Metro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
A charge with Hdfc Bank Limited of Rs. 12.80 M registered on 27 Dec 2013 with Charge ID 10470050 was modified on 30 Oct 2022. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 1.40 M with Charge ID 100555886 was registered on 08 Mar 2022. was documented.
Seema Mahajan was appointed as a Director was appointed as a Director on 19 Dec 2018 & has been associated with this company since 6 years 11 months . was recorded as a recent event.
The CIN of Metro Pharmaceuticals Private Limited is U24239DL2000PTC103605.
Metro Pharmaceuticals Private Limited is headquartered at I-45 Lajpat Nagar-1, Delhi, Delhi, 110024.
Metro Pharmaceuticals Private Limited was incorporated on 04 February 2000.
The current directors of Metro Pharmaceuticals Private Limited are
The primary industry of Metro Pharmaceuticals Private Limited is Trade.
Metro Pharmaceuticals Private Limited is unlisted.
The authorized capital of Metro Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Metro Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX